Assisted Reproduction Safety and Risks

Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization

Dessole S, Rubattu G, Ambrosini G, Miele M, Nardelli GB, Cherchi PL

Published July 5, 2001 Fertility and Sterility, 76(1), 205-206
DOI 10.1016/s0015-0282(01)01858-1 PMID 11438346

RRM Academy Synopsis

Estimated blood loss in uncomplicated IVF retrieval was about 230 mL

Noncomplicated IVF egg retrieval led to an average estimated blood loss of 230 mL. A prospective study of 220 women aged 25 to 42, none overweight or obese, used blood counts from before and one day after retrieval to calculate blood loss. Follicle count, egg count, and procedure time showed no significant correlation with the amount lost.

Study at a glance, prospective study: Blood loss at uncomplicated egg retrieval did not track follicle or egg counts
Study at a glance, prospective study of 220 women: Blood loss at uncomplicated egg retrieval did not track follicle or egg counts. Source: Dessole S et al., 2001, PMID 11438346.

Key Findings

  • Among 220 women, mean estimated blood loss was 232.4 mL (standard deviation 130.8) by the surface-area method.
  • The authors report about 230 mL as the estimated blood loss roughly 24 hours after retrieval and suggest it as a reference value for normal loss in noncomplicated retrieval.
  • None of the enrolled women had a complication.
  • In these 220 women, blood loss showed no statistically significant correlation with the number of follicles aspirated, eggs retrieved, estrogen level before ovulation, or procedure length.

Interpretation

The authors estimated blood loss indirectly. They compared blood counts from before retrieval and one day after, then applied published blood-volume formulas. The study followed a single group of 220 women. It excluded women with overweight, obesity, low platelets, blood-thinning drugs, or ovarian hyperstimulation syndrome. No enrolled woman had a complication, so the paper reports nothing on blood loss in complicated retrievals. The authors conclude that the factors they examined cannot serve as risk markers for heavier loss.

RRM Context

The authors say puncturing follicles to collect eggs inevitably damages small blood vessels on the ovary. IVF bypasses ovulation and goes ahead without finding why conception has not happened. Restorative reproductive medicine looks for that cause in both partners and works with the woman's own ovulatory cycle.

Abstract

Transvaginal ultrasonic follicle puncture has now become the method of choice for oocyte retrieval among most in vitro fertilization (IVF) units. The procedure, which involves puncture then aspiration of ovarian follicles, inevitably results in damage to the fine vascular network of blood vessels on the ovarian surface and theca interna layer, and tends to produce varying degrees of blood loss. The transvaginal ultrasonically guided retrieval of oocytes can be considered noncomplicated when the procedure does not result in injury to iliac vessels, trauma to pelvic viscera, or iatrogenic pelvic infections (1, 2), which would necessitate laparoscopy and or laparotomy. The aim of our study was to quantify the amount of blood loss that should be considered “normal” after noncomplicated transvaginal ultrasonically guided retrieval of oocytes, to characterize the factors that are related to the amount of blood loss, and to identify the patients who have the highest risk of hemorrhage. Before beginning our study, we performed a power analysis of potential participants. We established the sample size after evaluating the number of women of fertile age in our area, and we used the previous years’ data to calculate the prevalence of sterility problems and the percentage of women who had undergone in vitro fertilization. Thus, our prospective study was based on a sample of 220 women, 25 to 42 years old, who underwent assisted reproduction from January 1998 to May 1999. We excluded the women who had mild or severe ovarian hyperstimulation syndrome or thrombocytopenia, those who were taking anticoagulant drugs, and those who were overweight (body mass index 25 to 30) or obese (body mass index greater than 30). The study was approved by the local hospital ethics committee and all of the participants gave written informed consent.

Topics

By this author

Related research

Assisted Reproduction › Safety and Risks › Procedural Safety
Salvatore Dessole, Giovanni Rubattu, Guido Ambrosini, Maddalena Miele, Giovanni Battista Nardelli, Pier Luigi Cherchi
S Dessole, G Rubattu, G Ambrosini, M Miele, G Nardelli, P Cherchi
PMID 11438346 11438346 DOI 10.1016/s0015-0282(01)01858-1 10.1016/s0015-0282(01)01858-1 Dessole et al. 2001, Dessole 2001